U Announces Life-Saving Lab Pushing Limits of Medical Technology

Posted on

The University of Utah, one of the nation’s leading research universities, has just announced the launch of a new laboratory called the Applied MedicalEngineering (AME) Lab. The AME Lab’s ambitious mission is to create cutting-edge medical technologies designed to deliver life-saving care to any patient with any injury at any location for any duration. The […]

Read More

NUSANO AND STARGET PHARMA ANNOUNCE SUPPLY AGREEMENT TO ACCELERATE SMART TARGETED RADIOLIGAND DEVELOPMENT

VALENCIA, Calif. and TEL AVIV, Israel – Oct. 17, 2024 – Nusano, a physics company transforming the production of radioisotopes, and Starget Pharma, a clinical-stage biotechnology company developing precision peptide radioligand therapies focused on difficult to treat cancers, today announced a supply agreement to advance the development of Starget’s Smart Targeted Radioligands (STRs). The supply […]

Read More

Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration

Posted on

Myriad’s MyRisk® test is the first hereditary cancer test integrated into Flatiron’s OncoEMR® SALT LAKE CITY, Oct. 15, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a collaboration with Flatiron Health, a leading health tech company dedicated to expanding the possibilities of point of care […]

Read More

Halia Therapeutics to Participate in Panel at BIO Investor Forum 2024

Posted on

LEHI, Utah, Oct. 14, 2024 /PRNewswire/ — Halia Therapeutics, Inc. (Halia), a clinical-stage biopharmaceutical company at the forefront of developing innovative treatments for inflammatory and neurodegenerative diseases, today announced that David J. Bearss, Ph.D., President and CEO of Halia Therapeutics, will participate in a panel at the BIO Investor Forum taking place October 15-16, 2024, in […]

Read More

Canary Speech Launches Canary Ambient™, a First-of-its-Kind, Real-Time Voice Analysis for Clinical Conversations

Posted on

Canary Ambient™ enables actionable insights into patient-clinician dialogues, tracking speech patterns, and delivering real-time evaluations of cognitive and behavioral health conditions PROVO, Utah, Oct. 16, 2024 /PRNewswire/ — Canary Speech, a leader in vocal biomarker technology, has announced today the launch of Canary Ambient™, an API-first solution designed for healthcare and contact centers, which offers a […]

Read More

Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access

Posted on

SALT LAKE CITY, Oct. 16, 2024 (GLOBE NEWSWIRE) — Myriad Genetics Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a strategic partnership with jscreen™, a national organization that delivers education and access to preventative genetic testing with a focus on high-risk populations. The collaboration combines the strengths of Myriad’s high-quality […]

Read More

Canyon Labs Expands Capabilities With Acquisition of Life Pack Labs

Utah-based Canyon Labs announces its strategic acquisition of Life Pack Labs in California, broadening its service offerings and enhancing its position as an industry leader in medical device and pharmaceutical compliance testing. SALT LAKE CITY, October 8, 2024 (Newswire.com) – Canyon Labs, a leading medical device & pharmaceutical consulting, sterility assurance, analytical chemistry and package […]

Read More

Scientists at Utah State University Receive Grants to Study Two Important Viruses

Posted on

Researchers at Utah State University, led by Professor Zhongde Wang and collaborating with teams at University of Texas Medical Branch and University of Pittsburgh, respectively, have secured two grants from the National Institutes of Health (NIH) totaling more than $4 million in recent months to advance the understanding of two important global health threats. In […]

Read More

Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan

Posted on

SALT LAKE CITY, Sept. 24, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced Company representatives will be accompanying Utah Governor Cox and the Governor’s Office of Economic Opportunity, as part of the latest World Trade Center (WTC) Utah trade […]

Read More

BioUtah and Coalition of Patient Advocates Talk PBM Reform with U.S. Reps. Blake Moore and Celeste Maloy

BioUtah’s VP for Government Affairs, Denise Bell, along with a coalition of patient advocates, life sciences executives, pharmacists, physicians, oncologists, and community organizations, held a lunch meeting with Representatives Blake Moore (R-UT) and Celeste Maloy (R-UT) October 1 to discuss the dangers of giving pharmacy benefit managers (PBMs) command over how much patients pay for […]

Read More

BioUtah Member BBQ Recap

BioUtah’s annual membership appreciation BBQ was held yesterday at the Gateway’s Hidden Gem Patio. The event was a great way for the nearly 200 registrants to network with colleagues and make new connections. Prior to the BBQ, an executive reception was held, with several BioUtah Board members present. Also, in conjunction with the BBQ, the […]

Read More